Literature DB >> 8225820

Platinum accumulation in the kidney and liver following chemotherapy with cisplatin in humans.

J Uozumi1, T Ueda, T Yasumasu, Y Koikawa, S Naito, J Kumazawa, K Sueishi.   

Abstract

Platinum (Pt) concentrations in the kidney and liver were determined in 12 autopsied cases following cisplatin treatment. The Pt level in the liver was generally higher than that in the kidney. Pt concentration in the liver showed a significant correlation with the total dose of cisplatin. However, no dose-dependent Pt accumulation was observed in the kidney. Kidney Pt levels were correlated with the doses of cisplatin injected within a 6-month period prior to the patient's death. It is suggested that the dose of cisplatin injected during a relatively short period before the patient's death affected the Pt concentration in the kidney.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225820

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  3 in total

Review 1.  Testicular cancer survivorship: research strategies and recommendations.

Authors:  Lois B Travis; Clair Beard; James M Allan; Alv A Dahl; Darren R Feldman; Jan Oldenburg; Gedske Daugaard; Jennifer L Kelly; M Eileen Dolan; Robyn Hannigan; Louis S Constine; Kevin C Oeffinger; Paul Okunieff; Greg Armstrong; David Wiljer; Robert C Miller; Jourik A Gietema; Flora E van Leeuwen; Jacqueline P Williams; Craig R Nichols; Lawrence H Einhorn; Sophie D Fossa
Journal:  J Natl Cancer Inst       Date:  2010-06-28       Impact factor: 13.506

2.  Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.

Authors:  A Johnsson; C Olsson; O Nygren; M Nilsson; B Seiving; E Cavallin-Stahl
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases.

Authors:  Moritz J Strowitzki; Praveen Radhakrishnan; Sandra Pavicevic; Jana Scheer; Gwendolyn Kimmer; Alina S Ritter; Christopher Tuffs; Claudia Volz; Florian Vondran; Jonathan M Harnoss; Johannes Klose; Thomas Schmidt; Martin Schneider
Journal:  Br J Cancer       Date:  2019-02-27       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.